PhD Science Writer, New York City, New York, USA.
Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences (SV) and School of Engineering (STI), Lausanne, Switzerland.
Ann N Y Acad Sci. 2022 Dec;1518(1):196-208. doi: 10.1111/nyas.14874. Epub 2022 Sep 30.
Complex three-dimensional in vitro organ-like models, or organoids, offer a unique biological tool with distinct advantages over two-dimensional cell culture systems, which can be too simplistic, and animal models, which can be too complex and may fail to recapitulate human physiology and pathology. Significant progress has been made in driving stem cells to differentiate into different organoid types, though several challenges remain. For example, many organoid models suffer from high heterogeneity, and it can be difficult to fully incorporate the complexity of in vivo tissue and organ development to faithfully reproduce human biology. Successfully addressing such limitations would increase the viability of organoids as models for drug development and preclinical testing. On April 3-6, 2022, experts in organoid development and biology convened at the Keystone Symposium "Organoids as Tools for Fundamental Discovery and Translation" to discuss recent advances and insights from this relatively new model system into human development and disease.
复杂的三维体外类器官模型,或称为类器官,提供了一种独特的生物学工具,与二维细胞培养系统相比具有明显的优势,二维细胞培养系统过于简单,而动物模型又过于复杂,可能无法再现人类生理学和病理学。在推动干细胞分化为不同类型的类器官方面已经取得了重大进展,但仍存在一些挑战。例如,许多类器官模型存在高度异质性,并且很难完全纳入体内组织和器官发育的复杂性,以真实再现人类生物学。成功解决这些限制将增加类器官作为药物开发和临床前测试模型的可行性。2022 年 4 月 3 日至 6 日,类器官开发和生物学领域的专家在 Keystone 研讨会“类器官作为基础发现和转化的工具”上齐聚一堂,讨论了这一相对较新的模型系统在人类发育和疾病方面的最新进展和研究成果。